Tower Research Capital (TRC)
PSIL icon

Tower Research Capital (TRC)’s AdvisorShares Psychedelics ETF PSIL Stock Holding History

Tower Research Capital (TRC)’s Portfolio PSIL Stock Details PSIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6
Closed -$78 – 6079
2023
Q4 		$78 Buy
+6
New +$85 ﹤0.01% 5731
2022
Q4 		– Sell
-74
Closed -$2K – 6262
2022
Q3 		$2K Buy
+74
New +$2.36K ﹤0.01% 5602

Other funds holding PSIL

Corient Private Wealth
Corient Private Wealth Miami, Florida $72.2B AUM 27.85% 1-Year Est. Return
Spire Wealth Management
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Perigon Wealth Management
Perigon Wealth Management San Francisco, California $6.5B AUM 20.72% 1-Year Est. Return
Glassman Wealth Services
Glassman Wealth Services Vienna, Virginia $835M AUM 22.94% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Janiczek Wealth Management
Janiczek Wealth Management Denver, Colorado $477M AUM 15.17% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Tower Research Capital (TRC)'s PSIL Position: Q1 2024 in Review

Tower Research Capital (TRC) sold out of AdvisorShares Psychedelics ETF (PSIL) in Q1 2024, closing a stake of 6 shares — an estimated $78 sold.

Tower Research Capital (TRC) first reported a position in PSIL in Q3 2022 and held it in 2 quarters. The position peaked at $2K in Q3 2022. 13 funds tracked by Wall St. Rank hold PSIL as of Q1 2024.

  • Tower Research Capital (TRC) reported no remaining AdvisorShares Psychedelics ETF position as of Q1 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 6 AdvisorShares Psychedelics ETF shares in Q1 2024, an estimated $78.
  • Tower Research Capital (TRC) first reported a position in AdvisorShares Psychedelics ETF in Q3 2022 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s AdvisorShares Psychedelics ETF position peaked at $2K in Q3 2022.
  • 13 funds tracked by Wall St. Rank held AdvisorShares Psychedelics ETF as of Q1 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.